Sophrosyne Technologies

Development of semiconductor solutions for healthcare, IoT, and AI applications.

About Sophrosyne Technologies

Sophrosyne Technologies is a Healthcare company. Development of semiconductor solutions for healthcare, IoT, and AI applications. It operates in the Healthcare and Technology sectors. Sophrosyne Technologies has raised $2 million across 2 funding rounds from investors including Bluehill.VC and Ministry of Electronics & Information Technology. The company has 1 employees. Sophrosyne Technologies offers products and services including IoT Chips and Edge AI Chipset. Its focus areas include Medical Devices, Remote Monitoring, Patient Vital Tracking and Semiconductors. Its legal entity in India is Sophrosyne Technologies Private Limited (U72900KA2022PTC158233).

Company details

Sophrosyne Technologies is recognized for its contributions to the semiconductor ecosystem, where research and innovation are emphasized in developing IoT-enabled chips and AI solutions for healthcare. Products such as Bluetooth and 5G chips, edge AI chipsets, wearable devices, and cloud-based software are being created to support remote patient monitoring, addressing lifestyle diseases in India through collaborations with medical experts. Data privacy is maintained via advanced security measures, ensuring reliable health insights for practitioners and families.

Key Metrics
  • Total Equity Funding
    $2M (USD)

    in 2 rounds

  • Latest Funding Round
    $1.2M (USD), Grant

    Dec 2025

  • Investors
  • Employee Count
    1

Products & Services of Sophrosyne Technologies

Sophrosyne Technologies offers a comprehensive portfolio of products and services, including IoT Chips and Edge AI Chipset.

IoT Chips
Semiconductor Devices

IoT chips are designed for real-time data transmission in healthcare monitoring, with features like ultra-low power consumption.

Edge AI Chipset
AI Hardware

Edge AI Chipsets are engineered for rapid processing and real-time decision-making in medical emergencies using sophisticated data modeling.

Funding Insights of Sophrosyne Technologies

Sophrosyne Technologies has successfully raised a total of $2M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $1.2 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $2M
  • Total Rounds 2
  • Last Round Grant β€” $1.2M
  • First Round $2M

    (Nov 2025)

  • Investors Count 2

All 2 funding rounds of Sophrosyne Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2025$1.2MGrant––
Nov 2025$2MSeed––
Valuation history

2 investors in total: 2 institutional.

Investors in Sophrosyne Technologies

Sophrosyne Technologies has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Bluehill.VC and Ministry of Electronics & Information Technology.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital investments are provided by Bluehill.VC.
bluehill.vc
meity.gov.in
Premium access

Investor details for Sophrosyne Technologies

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Sophrosyne Technologies Private Limited (Sophrosyne Technologies)

Sophrosyne Technologies Private Limited is the primary company behind Sophrosyne Technologies. The board of Sophrosyne Technologies Private Limited currently have 3 directors; the longest-serving is Sivuni Neeraja, appointed in 2022.

DirectorDesignationAppointedTenureEntity
Sivuni Neeraja
DIN 07234689
Director22 Feb 20224 yrs 8 moSophrosyne Technologies Private Limited
Manish Srivastava
DIN 09515336
Director22 Feb 20224 yrs 8 moSophrosyne Technologies Private Limited
Jatin Gupta
DIN 10879843
Director23 Dec 20241 yr 10 moSophrosyne Technologies Private Limited

Timeline of Sophrosyne Technologies

2 dated milestones of Sophrosyne Technologies, from founding to its latest funding, stage changes and deals.

  1. Funding First funding round of $2.0M.
  2. Funding Latest funding round, Grant, of $1.2M.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Sophrosyne Technologies

Premium access

Complete news archive for Sophrosyne Technologies

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sophrosyne Technologies

Sophrosyne Technologies is a funded company, having raised a total of $2M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2M, raised on Nov 2025.

Sophrosyne Technologies has 1 employees.

Sophrosyne Technologies is recognized for its contributions to the semiconductor ecosystem, where research and innovation are emphasized in developing IoT-enabled chips and AI solutions for healthcare. Products such as Bluetooth and 5G chips, edge AI chipsets, wearable devices, and cloud-based software are being created to support remote patient monitoring, addressing lifestyle diseases in India through collaborations with medical experts. Data privacy is maintained via advanced security measures, ensuring reliable health insights for practitioners and families.

Sophrosyne Technologies offers IoT Chips and Edge AI Chipset.

Sophrosyne Technologies has 2 investors. Key investors include Bluehill.VC, and Ministry of Electronics & Information Technology.

Sophrosyne Technologies operates through Sophrosyne Technologies Private Limited.

The legal entities of Sophrosyne Technologies currently have 3 directors, including Sivuni Neeraja, Manish Srivastava, Jatin Gupta.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available